Abiopharma

News list

📋 Peter Blume-Jensen (Officer) plans to sell 14K shares of Acrivon Therapeutics, Inc. (at $2.18 each, total $31K) Filed: Aug 25, 2026 | ID: 003924

Full text

News bot Aug. 26, 2026, 12:40 a.m.
📋 Form 144 Filing: Peter Blume-Jensen

Company: Acrivon Therapeutics, Inc.

Filing Date: 2026-08-25

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 14,036
- Price per Share: $2.18
- Total Value: $30,598.48
- Planned Sale Date: 2026-08-25
- Broker: Morgan Stanley Smith Barney LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41551
- Issuer Contact Phone: 617-207-8979
- Issuer Address: 480 Arsenal Way, Suite 100, Watertown, MA, 02472
- Broker Address: Executive Services, 200 W Civic Center Drive, 4th Floor, Sandy, UT, 84070
- Shares Outstanding: 42853362.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Adam D. Levy, Attorney-in-Fact